Beneficient
Nasdaq · CIK 0001775734 · Fiscal year end 0331
Latest reported period: Latest published period
Revenue
$-39.1M
Operating Income
$-166.5M
Net Income
$-87.4M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $-39.1M | - | - |
| Operating Income | $-166.5M | - | - |
| Net Income | $-87.4M | - | - |
| Cash And Equivalents | $2.5M | - | - |
| Total Assets | $238.8M | - | - |
| Total Liabilities | $337.5M | - | - |
| Operating Cash Flow | $-38.7M | - | - |
| Capital Expenditures | $96,000 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-K | Beneficient | 2026-06-30 | 0001775734-26-000018 |
| 10-Q | Beneficient | 2026-02-17 | 0001775734-26-000012 |
| 4 | Beneficient | 2025-12-09 | 0001493152-25-026991 |
| 4 | Beneficient | 2025-12-09 | 0001493152-25-026990 |
| 10-Q | Beneficient | 2025-11-14 | 0001775734-25-000049 |
| 10-Q | Beneficient | 2025-10-20 | 0001775734-25-000038 |
| 10-K | Beneficient | 2025-09-29 | 0001775734-25-000022 |